CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.
about
The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neuronsHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesCannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responsesEpigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in OffspringSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsCB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationPharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategiesCB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Cannabinoids as novel anti-inflammatory drugs.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosisUse of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseThe role of endocannabinoids in pain modulation.Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors.Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis.CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDSEffects of Cannabinoids on T-cell Function and Resistance to Infection.CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.Hydrogen-rich saline protects immunocytes from radiation-induced apoptosisProlonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNSDo cannabinoids have a therapeutic role in transplantation?The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.Acute Thymic Involution and Mechanisms for Recovery.Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment.Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.
P2860
Q24602152-3797D9AA-5DF2-489F-AC75-ED16A7003EF6Q24631675-2BD1CF85-087A-47C9-9851-257CBF74858CQ24633610-30A629E5-4386-47D1-840E-AD785C85C393Q26864359-4B7D4F03-F8F4-4598-AC95-52FC7784CB3BQ27010555-0A742A05-B3E2-43ED-81B7-122CFA8EB00BQ28072822-5EA21FEB-9010-4377-8F52-94BCD8547C94Q28241318-4848BA6F-E005-4BBC-A265-4A2BD09076A9Q33488512-797ACEF4-0146-40D0-B621-CCC1D3DDF3A6Q33688381-B6C19334-E43F-4A45-BFCC-9BDF0CB40AF2Q33908169-082BB294-1876-4B95-B26A-530E958A8092Q33984006-0065E457-1D7C-4D80-9656-24A0760750CEQ34069579-0864345E-4437-40BD-B134-293D754631F9Q34188446-8E204FA0-F9AC-4D17-ADE7-38478CD0AFFDQ34320270-15AE9880-6416-42FD-8FA8-3A809603DEDDQ34461610-04D3D810-0910-48A5-83F4-33FC650F3535Q34471868-769C33C3-85F4-4D39-BE00-91B57789871BQ34471928-428FD8BB-8DC2-4888-919A-7D9B690A6F0DQ34591087-ACF861EA-165C-4C54-BC12-269908C32C42Q34712554-7BBE62C5-0C5B-4D41-94BF-DEFB2652BB8CQ34733645-A6300DF1-676A-4D8E-B251-AB388AA57B6BQ35028750-81DD32BC-7019-4C19-A751-631C93CAF942Q35752185-7E203929-1D0A-46FD-8C59-2FD1390AC3C2Q35870490-EEE7BF9B-FDD5-46B1-BDCC-FA61168165C7Q36416330-5585FA8A-EC36-4D51-B691-63FE797A6126Q36577750-A38D3252-5B12-4C7E-AE36-72C7CDCF3343Q36799355-847835FC-D0F1-4033-B692-D76A65327CDDQ36949750-3F779886-9332-4EB5-B03B-C04D505C40A6Q36961126-96C1D5A1-225F-4EFD-A27C-56839ECAFCECQ37371891-15A6E68A-0E1F-4452-865D-AD0D53E68ED8Q37396781-CBF7A67B-214C-4FBB-A451-68EAEB7887BFQ37490376-049EB141-E499-4941-B60D-648937953A1EQ37531460-45DE19FA-15A8-408B-A7EF-640A5E389105Q37768965-3887D195-04B5-48C1-A2C2-4AB4F28C7F60Q38072364-25AE4E4A-2D36-4563-A7F0-6D9AB5A0B0C4Q38087533-367E6347-3776-4ACC-87F4-2665DB7C33ACQ39194971-9072D81A-A313-40FA-8D44-A7F306D0D3C6Q40044046-7B0858BE-2E77-4CF3-B6DF-F287A4F45749Q47965888-FCD06AAF-B689-4DCE-8939-132B9EE90E9FQ48136562-53FC8A0D-0A92-47A7-809F-8B425E38430FQ53533652-9B310330-6C9A-4BEA-96B1-2B96C30FB585
P2860
CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
CB2 cannabinoid receptor agoni ...... s as immunosuppressive agents.
@ast
CB2 cannabinoid receptor agoni ...... s as immunosuppressive agents.
@en
type
label
CB2 cannabinoid receptor agoni ...... s as immunosuppressive agents.
@ast
CB2 cannabinoid receptor agoni ...... s as immunosuppressive agents.
@en
prefLabel
CB2 cannabinoid receptor agoni ...... s as immunosuppressive agents.
@ast
CB2 cannabinoid receptor agoni ...... s as immunosuppressive agents.
@en
P2860
P921
P1433
P1476
CB2 cannabinoid receptor agoni ...... ds as immunosuppressive agents
@en
P2093
Mitzi Nagarkatti
Prakash Nagarkatti
P2860
P304
P356
10.1016/J.CLIM.2006.11.002
P577
2006-12-20T00:00:00Z